Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Vape and Aviate: Electronic-Cigarette Use and Misuse in Naval Aviation.

Hall MT, Austin RP, Do TA, McGlynn A.

Mil Med. 2018 Mar 1;183(3-4):e165-e170. doi: 10.1093/milmed/usx003.

PMID:
29365191
2.

Erratum to "Survival of the Fittest: Time-To-Event Modelling of Crystallisation of Amorphous Poorly Soluble Drugs".

Nurzyńska K, Austin RP, Fischer PM, Booth J, Gommer F.

J Pharm Sci. 2016 Nov;105(11):3464. doi: 10.1016/j.xphs.2016.09.012. No abstract available.

PMID:
27742164
3.

Survival of the Fittest: Time-To-Event Modeling of Crystallization of Amorphous Poorly Soluble Drugs.

Nurzyńska K, Austin RP, Fischer PM, Booth J, Gommer F.

J Pharm Sci. 2016 Jun;105(6):1858-1866. doi: 10.1016/j.xphs.2016.03.014. Erratum in: J Pharm Sci. 2016 Nov;105(11):3464.

4.

Right lower quadrant abdominal pain, fever, and hypotension: an atypical presentation of meningococcemia.

Austin RP, Field AG, Beer WM.

Am J Emerg Med. 2015 Nov;33(11):1713.e3-4. doi: 10.1016/j.ajem.2015.03.028. Epub 2015 Mar 16. No abstract available.

PMID:
25825033
5.

Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists.

Austin RP, Bennion C, Bonnert RV, Cheema L, Cook AR, Cox RJ, Ebden MR, Gaw A, Grime K, Meghani P, Nicholls D, Phillips C, Smith N, Steele J, Stonehouse JP.

Bioorg Med Chem Lett. 2015 Apr 1;25(7):1616-20. doi: 10.1016/j.bmcl.2015.01.067. Epub 2015 Feb 3.

PMID:
25708618
6.

Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.

Nicholls DJ, Jordan S, Cadogan E, Lawson M, Austin RP, Paine SW, Gardiner P, Bonnert R, Connolly S, Young A.

Pulm Pharmacol Ther. 2012 Aug;25(4):293-302. doi: 10.1016/j.pupt.2012.05.008. Epub 2012 May 29.

PMID:
22659538
7.

The effect of ionized species on microsomal binding.

Abraham MH, Austin RP.

Eur J Med Chem. 2012 Jan;47(1):202-5. doi: 10.1016/j.ejmech.2011.10.043. Epub 2011 Nov 4.

PMID:
22093757
8.

A highly automated assay for determining the aqueous equilibrium solubility of drug discovery compounds.

Wenlock MC, Austin RP, Potter T, Barton P.

J Lab Autom. 2011 Aug;16(4):276-84. doi: 10.1016/j.jala.2010.10.002. Epub 2011 Mar 26.

PMID:
21764023
9.

A kinetic method for the determination of plasma protein binding of compounds unstable in plasma: Specific application to enalapril.

Wenlock MC, Barton P, Austin RP.

J Pharm Biomed Anal. 2011 Jun 1;55(3):385-90. doi: 10.1016/j.jpba.2011.02.006. Epub 2011 Mar 2.

PMID:
21371844
10.

A method for measuring the lipophilicity of compounds in mixtures of 10.

Wenlock MC, Potter T, Barton P, Austin RP.

J Biomol Screen. 2011 Mar;16(3):348-55. doi: 10.1177/1087057110396372. Epub 2011 Feb 22.

PMID:
21343602
11.

Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs.

McGinnity DF, Collington J, Austin RP, Riley RJ.

Curr Drug Metab. 2007 Jun;8(5):463-79.

PMID:
17584017
12.

The thermodynamics of the partitioning of ionizing molecules between aqueous buffers and phospholipid membranes.

Austin RP, Barton P, Davis AM, Fessey RE, Wenlock MC.

Pharm Res. 2005 Oct;22(10):1649-57. Epub 2005 Sep 22.

PMID:
16180122
13.

A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.

Riley RJ, McGinnity DF, Austin RP.

Drug Metab Dispos. 2005 Sep;33(9):1304-11. Epub 2005 Jun 2.

PMID:
15932954
14.

The binding of drugs to hepatocytes and its relationship to physicochemical properties.

Austin RP, Barton P, Mohmed S, Riley RJ.

Drug Metab Dispos. 2005 Mar;33(3):419-25. Epub 2004 Dec 22.

PMID:
15616151
15.

Are you taking more meds than you need?

Austin RP.

Diabetes Forecast. 2004 Jun;57(6):48-50. No abstract available.

PMID:
15195627
16.

Structure-reactivity relationships in the inactivation of elastase by beta-sultams.

Hinchliffe PS, Wood JM, Davis AM, Austin RP, Beckett RP, Page MI.

Org Biomol Chem. 2003 Jan 7;1(1):67-80.

PMID:
12929392
17.

QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists.

Austin RP, Barton P, Bonnert RV, Brown RC, Cage PA, Cheshire DR, Davis AM, Dougall IG, Ince F, Pairaudeau G, Young A.

J Med Chem. 2003 Jul 17;46(15):3210-20.

PMID:
12852752
18.

Lung cancer mortality among chromate production workers.

Luippold RS, Mundt KA, Austin RP, Liebig E, Panko J, Crump C, Crump K, Proctor D.

Occup Environ Med. 2003 Jun;60(6):451-7.

19.

A comparison of physiochemical property profiles of development and marketed oral drugs.

Wenlock MC, Austin RP, Barton P, Davis AM, Leeson PD.

J Med Chem. 2003 Mar 27;46(7):1250-6.

PMID:
12646035
20.

The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.

Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ.

Drug Metab Dispos. 2002 Dec;30(12):1497-503.

PMID:
12433825
21.

Hydrolysis of a sulfonamide by a novel elimination mechanism generated by carbanion formation in the leaving group.

Wood JM, Hinchliffe PS, Davis AM, Austin RP, Page MI.

Chem Commun (Camb). 2002 Apr 7;(7):772-3.

PMID:
12119716
22.

Historical cohort study of 10 109 men in the North American vinyl chloride industry, 1942-72: update of cancer mortality to 31 December 1995.

Mundt KA, Dell LD, Austin RP, Luippold RS, Noess R, Bigelow C.

Occup Environ Med. 2000 Nov;57(11):774-81.

23.

The effect of ionic strength on liposome-buffer and 1-octanol-buffer distribution coefficients.

Austin RP, Barton P, Davis AM, Manners CN, Stansfield MC.

J Pharm Sci. 1998 May;87(5):599-607.

PMID:
9572911
24.

Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles.

Austin RP, Davis AM, Manners CN.

J Pharm Sci. 1995 Oct;84(10):1180-3.

PMID:
8801331
25.

Comment: Extending admixtures' time of exclusivity.

Austin RP.

Drug Intell Clin Pharm. 1987 Dec;21(12):1013. No abstract available.

PMID:
3428155
26.

Diversion of butorphanol.

Austin RP.

Am J Hosp Pharm. 1983 Aug;40(8):1306. No abstract available.

PMID:
6614013

Supplemental Content

Loading ...
Support Center